X-LINKED HYPOPHOSPHATEMIA
Clinical trials for X-LINKED HYPOPHOSPHATEMIA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED HYPOPHOSPHATEMIA trials appear
Sign up with your email to follow new studies for X-LINKED HYPOPHOSPHATEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone disease: first human trial of KK8123 begins
Disease control Recruiting nowThis study tests a new drug called KK8123 for adults with X-linked hypophosphatemia (XLH), a rare genetic condition that causes low phosphate levels and bone problems. The trial has two parts: first, finding the right dose, then checking safety and how well it works over time. Ab…
Matched conditions: X-LINKED HYPOPHOSPHATEMIA
Phase: PHASE1, PHASE2 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple scan reveal why muscles tire in phosphate diabetes?
Knowledge-focused Recruiting nowThis study uses a special MRI technique to measure energy molecules (ATP and phosphate) in the leg muscles of people with phosphate diabetes, a condition that causes bone pain and muscle fatigue. By comparing measurements at rest and during exercise, researchers hope to uncover t…
Matched conditions: X-LINKED HYPOPHOSPHATEMIA
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Global XLH registry aims to map the disease's journey from childhood to adulthood
Knowledge-focused Recruiting nowThis study is a worldwide registry that collects health information from people of all ages with X-Linked Hypophosphatemia (XLH), a rare genetic condition that affects bone growth and strength. Researchers will track how the disease progresses, what treatments patients receive, a…
Matched conditions: X-LINKED HYPOPHOSPHATEMIA
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC